Cancer affecting the female reproductive organs such as the ovaries, uterus, cervix, vagina, or fallopian tubes.
During active disease and treatment, medical records confirming the diagnosis of a gynecological malignancy and documentation of ongoing surgical, radiation, chemotherapy, or other therapeutic treatment are the core evidence supporting a 100 percent rating. Oncology notes, pathology reports, operative reports, and treatment summaries all speak directly to this.
After treatment ends and the mandatory six-month examination occurs, the evidence that matters shifts to what residuals remain. Records documenting scars and their location, measurements, and effect on surrounding tissue support a scar-related rating. Lymphedema diagnoses with measurements and functional limitations support that residual. Records of disfigurement or any impairment of function in affected body systems are relevant as well. Statements from you describing how residual symptoms affect your daily activities and ability to work can help show the severity of those lasting effects. If there has been any loss or loss of use of a creative organ, medical records establishing that fact are relevant to a possible special monthly compensation determination.
Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.
